OP-3633

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameOP-3633
Drug Alias NameOP-3633
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOric Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOric Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A